共 7 条
- [1] Optimal treatment of acute coronary syndromes—an evolving strategy. Boden WE,McKay RG. The New England Journal of Medicine . 2001
- [2] Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein Ⅱb/Ⅲa inhibitor tirofiban. Cannon CP,Weintraub WS,Demopoulos LA,et al. The New England Journal of Medicine . 2001
- [3] Optimal timing for coronary stenting in unstable angina. Shen WF,Zhang RY,Shen Y,et al. Chinese Medical Journal . 2001
- [4] Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction: a TIMI ⅢB database study. Stone PH,Thompson B,Zaret BL,et al. European Heart Journal . 1999
- [5] Early angioplasty in acute coronary syndromes without persistent ST-segment elevation improves outcome but increases the need for six-month repeat revascularization: an analysis of the PURSUIT Trial. Ronner E,Boersma E,Laarman GJ,et al. Journal of the American College of Cardiology . 2002
- [6] Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes.PURSUIT Investigators. Kleiman NS,Lincoff AM,Flaker GC,et al. Circulation . 2000
- [7] ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Braunwald E,Antman EM,Beasley JW,et al. Journal of the American College of Cardiology . 2000